Header Logo

Connection

DAVID GRAHAM to Antigens, Bacterial

Back to Details
This is a "connection" page, showing publications DAVID GRAHAM has written about Antigens, Bacterial.
DAVID GRAHAM
Connection Strength
4.026
Antigens, Bacterial
  1. Monoclonal stool antigen testing for diagnosing Helicobacter pylori in young children: revisited. J Pediatr Gastroenterol Nutr. 2010 Sep; 51(3):373; author reply 373-4.
    View in: PubMed
    Score: 0.288
  2. CagA in Barrett's oesophagus in Colombia, a country with a high prevalence of gastric cancer. J Clin Pathol. 2005 Mar; 58(3):259-62.
    View in: PubMed
    Score: 0.197
  3. Helicobacter pylori strain and the pattern of gastritis among first-degree relatives of patients with gastric carcinoma. Helicobacter. 2002 Dec; 7(6):349-55.
    View in: PubMed
    Score: 0.168
  4. Helicobacter pylori in North and South America before Columbus. FEBS Lett. 2002 Apr 24; 517(1-3):180-4.
    View in: PubMed
    Score: 0.161
  5. Clarifications regarding the 3' repeat region of the cagA gene in Helicobacter pylori and clinical outcome. J Clin Microbiol. 2001 Jun; 39(6):2369-70.
    View in: PubMed
    Score: 0.152
  6. Conservation of Helicobacter pylori genotypes in different ethnic groups in Houston, Texas. J Infect Dis. 2000 Jun; 181(6):2083-6.
    View in: PubMed
    Score: 0.142
  7. Molecular epidemiology of Helicobacter pylori: separation of H. pylori from East Asian and non-Asian countries. Epidemiol Infect. 2000 Feb; 124(1):91-6.
    View in: PubMed
    Score: 0.138
  8. Relation between clinical presentation, Helicobacter pylori density, interleukin 1beta and 8 production, and cagA status. Gut. 1999 Dec; 45(6):804-11.
    View in: PubMed
    Score: 0.137
  9. CagA status and gastric cancer unreliable serological tests produce unreliable data. Gastroenterology. 1999 Sep; 117(3):745.
    View in: PubMed
    Score: 0.134
  10. Characterization of Mycobacterium paratuberculosis p36 antigen and its seroreactivities in Crohn's disease. Curr Microbiol. 1999 Aug; 39(2):115-9.
    View in: PubMed
    Score: 0.134
  11. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol. 1999 Jul; 37(7):2274-9.
    View in: PubMed
    Score: 0.133
  12. Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer. J Clin Pathol. 1999 Mar; 52(3):215-8.
    View in: PubMed
    Score: 0.130
  13. Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome. Helicobacter. 1998 Dec; 3(4):241-53.
    View in: PubMed
    Score: 0.128
  14. H. pylori and cagA: relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications. Helicobacter. 1998 Sep; 3(3):145-51.
    View in: PubMed
    Score: 0.125
  15. Characterization of a specific Mycobacterium paratuberculosis recombinant clone expressing 35,000-molecular-weight antigen and reactivity with sera from animals with clinical and subclinical Johne's disease. J Clin Microbiol. 1997 Jul; 35(7):1794-9.
    View in: PubMed
    Score: 0.116
  16. Helicobacter pylori as an oncogenic pathogen, revisited. Expert Rev Mol Med. 2017 03 21; 19:e4.
    View in: PubMed
    Score: 0.113
  17. Helicobacter pylori virulence and cancer pathogenesis. Future Oncol. 2014 Jun; 10(8):1487-500.
    View in: PubMed
    Score: 0.093
  18. CagA-dependent downregulation of B7-H2 expression on gastric mucosa and inhibition of Th17 responses during Helicobacter pylori infection. J Immunol. 2013 Oct 01; 191(7):3838-46.
    View in: PubMed
    Score: 0.089
  19. Helicobacter pylori virulence factor genotypes in children in the United States: clues about genotype and outcome relationships. J Clin Microbiol. 2010 Jul; 48(7):2550-1.
    View in: PubMed
    Score: 0.070
  20. CpG methylation and reduced expression of O6-methylguanine DNA methyltransferase is associated with Helicobacter pylori infection. Gastroenterology. 2010 May; 138(5):1836-44.
    View in: PubMed
    Score: 0.069
  21. N-acetylneuraminyllactose-binding fibrillar hemagglutinin of Campylobacter pylori: a putative colonization factor antigen. Infect Immun. 1988 Nov; 56(11):2896-906.
    View in: PubMed
    Score: 0.063
  22. Mannose-resistant hemagglutination of human erythrocytes by enterotoxigenic Escherichia coli with colonization factor antigen II. J Clin Microbiol. 1988 Sep; 26(9):1626-9.
    View in: PubMed
    Score: 0.063
  23. Evaluation of a novel stool native catalase antigen test for Helicobacter pylori infection in asymptomatic North American children. J Pediatr Gastroenterol Nutr. 2008 Apr; 46(4):399-402.
    View in: PubMed
    Score: 0.061
  24. Regulation of IL-18 in Helicobacter pylori infection. J Immunol. 2008 Jan 15; 180(2):1207-16.
    View in: PubMed
    Score: 0.060
  25. Prevalence of cagA in relation to clinical presentation of Helicobacter pylori infection in Egypt. Scand J Infect Dis. 2008; 40(9):730-3.
    View in: PubMed
    Score: 0.060
  26. Mycobacterial aetiology of Crohn's disease: serologic study using common mycobacterial antigens and a species-specific glycolipid antigen from Mycobacterium paratuberculosis. Gut. 1986 Nov; 27(11):1353-6.
    View in: PubMed
    Score: 0.055
  27. Helicobacter pylori virulence factors: facts and fantasies. Curr Opin Gastroenterol. 2005 Nov; 21(6):653-9.
    View in: PubMed
    Score: 0.052
  28. B-cell and T-cell immune responses to experimental Helicobacter pylori infection in humans. Infect Immun. 2005 May; 73(5):2999-3006.
    View in: PubMed
    Score: 0.050
  29. Role of interferon-stimulated responsive element-like element in interleukin-8 promoter in Helicobacter pylori infection. Gastroenterology. 2004 Apr; 126(4):1030-43.
    View in: PubMed
    Score: 0.046
  30. Relation between seroreactivity to low-molecular-weight Helicobacter pylori-specific antigens and disease presentation. Clin Diagn Lab Immunol. 2003 Nov; 10(6):1025-8.
    View in: PubMed
    Score: 0.045
  31. The changing epidemiology of GERD: geography and Helicobacter pylori. Am J Gastroenterol. 2003 Jul; 98(7):1462-70.
    View in: PubMed
    Score: 0.044
  32. Evaluation of the effects of strain-specific antigen variation on the accuracy of serologic diagnosis of Helicobacter pylori infection. J Clin Microbiol. 2003 Apr; 41(4):1480-5.
    View in: PubMed
    Score: 0.043
  33. New serological assay for detection of putative Helicobacter pylori virulence factors. J Clin Microbiol. 2002 Dec; 40(12):4753-6.
    View in: PubMed
    Score: 0.042
  34. Genomic fingerprinting and genotyping of Helicobacter pylori strains from patients with duodenal ulcer or gastric cancer from different geographic regions. Dig Dis Sci. 2002 Nov; 47(11):2512-8.
    View in: PubMed
    Score: 0.042
  35. Clinical presentation in relation to diversity within the Helicobacter pylori cag pathogenicity island. Am J Gastroenterol. 2002 Sep; 97(9):2231-8.
    View in: PubMed
    Score: 0.041
  36. Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis. Circulation. 2002 Jul 23; 106(4):430-4.
    View in: PubMed
    Score: 0.041
  37. Discrimination between cases of duodenal ulcer and gastritis on the basis of putative virulence factors of Helicobacter pylori. J Clin Microbiol. 2002 Jun; 40(6):2244-6.
    View in: PubMed
    Score: 0.041
  38. Specific seroreactivity of Crohn's disease patients against p35 and p36 antigens of M. avium subsp. paratuberculosis. Vet Microbiol. 2000 Dec 20; 77(3-4):497-504.
    View in: PubMed
    Score: 0.037
  39. Helicobacter pylori. Med Clin North Am. 2000 Sep; 84(5):1125-36, viii.
    View in: PubMed
    Score: 0.036
  40. Relationship between the cagA 3' repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology. 1999 Aug; 117(2):342-9.
    View in: PubMed
    Score: 0.033
  41. Molecular relationships of Helicobacter pylori strains in a family with gastroduodenal disease. Am J Gastroenterol. 1999 Feb; 94(2):364-8.
    View in: PubMed
    Score: 0.032
  42. Efficacy, immunogenicity, and safety of a parenteral vaccine against Helicobacter pylori in healthy volunteers challenged with a Cag-positive strain: a randomised, placebo-controlled phase 1/2 study. Lancet Gastroenterol Hepatol. 2018 10; 3(10):698-707.
    View in: PubMed
    Score: 0.031
  43. Genome and Methylome Variation in Helicobacter pylori With a cag Pathogenicity Island During Early Stages of Human Infection. Gastroenterology. 2018 02; 154(3):612-623.e7.
    View in: PubMed
    Score: 0.030
  44. Identification of a Latin American-specific BabA adhesin variant through whole genome sequencing of Helicobacter pylori patient isolates from Nicaragua. BMC Evol Biol. 2016 Feb 29; 16:53.
    View in: PubMed
    Score: 0.026
  45. Differences in interleukin 8 expression in Helicobacter pylori-infected gastric mucosa tissues from patients in Bhutan and the Dominican Republic. Hum Pathol. 2015 Jan; 46(1):129-36.
    View in: PubMed
    Score: 0.024
  46. Identification and characterization of Mycobacterium paratuberculosis recombinant proteins expressed in E. coli. Curr Microbiol. 1994 Sep; 29(3):177-84.
    View in: PubMed
    Score: 0.024
  47. Iron represses the expression of CFA/I fimbriae of enterotoxigenic E. coli. Microb Pathog. 1991 Nov; 11(5):317-23.
    View in: PubMed
    Score: 0.020
  48. Factors influencing the epidemiology of Helicobacter pylori infection in children. Pediatrics. 1991 Sep; 88(3):578-82.
    View in: PubMed
    Score: 0.019
  49. Paxillin is a novel cellular target for converging Helicobacter pylori-induced cellular signaling. Am J Physiol Gastrointest Liver Physiol. 2011 Oct; 301(4):G601-11.
    View in: PubMed
    Score: 0.019
  50. homB status of Helicobacter pylori as a novel marker to distinguish gastric cancer from duodenal ulcer. J Clin Microbiol. 2009 Oct; 47(10):3241-5.
    View in: PubMed
    Score: 0.017
  51. Relationship between Helicobacter pylori hopQ genotype and clinical outcome in Asian and Western populations. J Gastroenterol Hepatol. 2009 Mar; 24(3):462-8.
    View in: PubMed
    Score: 0.016
  52. Non-replicating oral whole cell vaccine protective against enterotoxigenic Escherichia coli (ETEC) diarrhea: stimulation of anti-CFA (CFA/I) and anti-enterotoxin (anti-LT) intestinal IgA and protection against challenge with ETEC belonging to heterologous serotypes. FEMS Microbiol Immunol. 1988 Dec; 1(3):117-25.
    View in: PubMed
    Score: 0.016
  53. Regulation of RANTES promoter activation in gastric epithelial cells infected with Helicobacter pylori. Infect Immun. 2005 Nov; 73(11):7602-12.
    View in: PubMed
    Score: 0.013
  54. Gastric mucosal cytokine levels in relation to host interleukin-1 polymorphisms and Helicobacter pyloricagA genotype. Scand J Gastroenterol. 2005 May; 40(5):530-9.
    View in: PubMed
    Score: 0.012
  55. Administration of purified colonization factor antigens (CFA/I, CFA/II) of enterotoxigenic Escherichia coli to volunteers. Response to challenge with virulent enterotoxigenic Escherichia coli. Gastroenterology. 1984 Oct; 87(4):934-40.
    View in: PubMed
    Score: 0.012
  56. Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads. Helicobacter. 2004 Oct; 9(5):453-9.
    View in: PubMed
    Score: 0.012
  57. Cyclooxygenase expression during Helicobacter pylori infection in Mongolian gerbils. Dig Dis Sci. 2003 Nov; 48(11):2139-46.
    View in: PubMed
    Score: 0.011
  58. Comparison of genotyping Helicobacter pylori directly from biopsy specimens and genotyping from bacterial cultures. J Clin Microbiol. 2003 Jul; 41(7):3336-8.
    View in: PubMed
    Score: 0.011
  59. Review article: Mycobacterium avium subsp. paratuberculosis as one cause of Crohn's disease. Aliment Pharmacol Ther. 2001 Mar; 15(3):337-46.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.